Showing results (71-80 of 566) with videos related to

Sort By:
Pageof 57
RMD Open|July 19, 2018
Latent profile analysis approach to the relationship between patient and physician global assessments of rheumatoid arthritis activityGeorge A Karpouzas, Vibeke Strand, Sarah R Ormseth
Drugs|February 2, 2026
Nanoencapsulated Sirolimus Plus Pegadricase (NASP) in Uncontrolled Gout: Current Status and Future DirectionsHerbert S B Baraf, Naomi Schlesinger, Vibeke Strand
Rheumatology and Therapy|March 3, 2017
Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of AbataceptLaure Gossec, Souhila Ahdjoudj, Evo Alemao, et al.
Annals of the Rheumatic Diseases|January 16, 2016
The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritisAtul Deodhar, Vibeke Strand, Jonathan Kay, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Withdrawal of therapy in non-renal systemic lupus erythematosus: is this an achievable goal?Marta Mosca, Chiara Tani, Martin Aringer
Rheumatic Diseases Clinics of North America|October 1, 2019
Treat to Target in Systemic Lupus ErythematosusMartin Aringer, Nicolai Leuchten, Matthias Schneider
Annals of the New York Academy of Sciences|July 25, 2012
Role of interleukin-6 in stress, sleep, and fatigueNicolas Rohleder, Martin Aringer, Matthias Boentert
Rheumatology (Oxford, England)|September 6, 2021
Glucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort studyLaura Felten, Nicolai Leuchten, Martin Aringer
Arthritis Care & Research|March 21, 2017
Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus ErythematosusStephanie G Nantes, Vibeke Strand, Jiandong Su, et al.
The Journal of Rheumatology|April 17, 2013
Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled studyVibeke Strand, Georg Schett, Chiachi Hu, et al.
Pageof 57